PAHC

NASD Phibro Animal Health Corporation Class A

Oct 3, 2026 · 2:20 PM ET EOD Market Closed

$37.24 ↑ +0.00 (+0.00%) Trading Up from the previous close of $37.24, $0.38 below the day’s high of $37.62

YTD change: -0.32%
vs 20-day SMA: +4.39%
vs 200-day SMA: -9.91%

Price ranges

Previous day

$36.19 $37.62

open $36.19 close $37.24

+$1.05 (+2.90%)

Today

$36.19 $37.62

$37.24

Past week

$33.52 $36.23

from $33.93 now $37.24

+$3.31 (+9.76%)

Past month

$33.05 $40.50

from $39.92 now $37.24

-$2.68 (-6.71%)

This year

$28.25 $60.08

from $37.36 now $37.24

-$0.12 (-0.32%)

Price & Performance

-17.70 (-32.22%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 38.0% away from all-time highs of $60.08
PAHC is down 0% since the beginning of the year
PAHC is down 5% over the past 12 months
PAHC is down 7% over the past 1 month
5% of all PAHC investors are betting against PAHC

PAHC reads very good: price sits above one of the two key moving averages, the 12-month move is -2.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $0.85

Earnings momentum -11.4% Quarterly EPS growth

Quarterly change -11.4%

Valuation

P/E ratio 14.71

Enterprise value $2.2B

Beta 0.01

Balance sheet & scale

Income$99.7K

Revenue$1.5B

Cash$82.0M

Debt$788.8K

Income / Debt 0.13×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $786.0M

Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment focuses on the development and marketing of medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment is involved in the manufacture and marketing of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

Competitor comparison

Ticker	Company	Price	Change
LLY	Eli Lilly and Company	$1,142.85	-0.61%
JNJ	Johnson & Johnson	$256.03	-1.02%
ABBV	AbbVie, Inc.	$262.82	+1.11%
MRK	Merck & Co., Inc.	$144.30	+0.34%
RHHVF	Roche Holding Ltd	$428.22	-3.25%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.